WE BUILD EXTRAORDINARY VENTURES

We breed startups that create value,
ultimately contributing to the common good.

Learn More

At adVentures, we breed innovative startups that create value, ultimately contributing to the common good.

We create ventures that enable efficiency and collaboration on a global scale. By combining technologies and entrepreneurial talents, we strive to overcome unanswered challenges.

We pioneer by taking calculated risks, leveraging technology whether that be digital, AI or genetics. And when appropriate, our scientists and engineers go beyond the frontiers. Our model favours frugal innovation and synergies across the portfolio.

We believe small teams make the boldest changes. We’ve built our studio as a learning organization, nurturing individuals, growing together as entrepreneurs.

Entrepreneurship is a craft, not a gamble.

Antoine Duboscq Picture

Antoine Duboscq
CEO adVentures Startup Studio

Teamwork solution

Genetic engineering deeptech

Know-how marketplace

Art Collections sharing platform

Global Market Niches

Our strategic mindset stresses the value of agility and creativity and is at the heart of all our initiatives. We spot early, or even create new global market niches that leverage technology.

A Unique Talent Pool

adVentures attracts talents from diverse business and scientific horizons, with a common mindset : global perspective, agility, hard work, high ethical standards, teamwork, willingness to make impactful contributions.

Building sustainable value

We manage our portfolio to create sustainable value, and mitigate the risks. Each venture is grown along specific value creation drivers and indicators. And each venture is expected to contribute to the common good.

Latest News

GEG TechNews
January 30, 2020

GEG-Tech presents Gene-Therapy Cancer Projects at Monaco International Summit

Monaco hosts every 2 years, an International Summit on Research Against Cancer: “Biennale Monégasque de Cancérologie – 2020 ”. Amongst the events, the Award Ceremony of The Prince Albert II…
Eloquens.com's LogoEloquensNews
November 23, 2019

Eloquens.com grows 10-fold reaching 100,000 professional users

Our know-how sharing platform, Eloquens.com has reached the milestone of 100,000 registered professionals. This is a 10-fold increase since January 2018 for this core KPI for the firm. Congratulations to…
Wimi Armoured LogoNewsWimi
June 7, 2019

Wimi launches Wimi Armoured

Wimi has just launched a new version of it's software: Wimi Armoured. This version of the collaborative platform has end-to-end encryption, offering a unique solution for efficient collaboration on sensitive…
GEG TechNews
May 20, 2019

GEG-Tech publishes a Scientific Review on Gene Therapy

GEG-Tech has released a comprehensive review on vectorisation technologies for Gene Therapy. The review covers recent advances in Science for this highly innovative area in bio-medicine. Gene therapy has made…
Wimi x AssNat - FeaturedNewsWimi
February 2, 2019

Wimi equips France’s Assemblée Nationale

Wimi has just started to work with France's "Assemblée Nationale." The french members of parliament will be using the collaboration software to work on their projects with their staff &…
Les EchosadVenturesNews
December 12, 2018

Les Echos – adVentures listed as a leading French startup studio

adVentures is listed as one of the leading startup studios in France according to Les Echos, one of the leading business newspapers in France. Indeed, adVentures was the first studio…
Antoine Duboscq - Les EchosadVenturesNews
December 12, 2018

Les Echos – Portrait of Antoine Duboscq (adVentures Founder)

The paper traces back the history of adVentures Startup Studio via Antoine Duboscq’s career and profile
Uart-first-platform-for-hotelsNewsUart
November 13, 2018

Uart: the First Platform for Art Hotels

Adventures Studio is proud that, this summer, Uart became the first platform for Hotels displaying Artworks. Among the 100'000 artworks visible on Uart, Art lovers can admire artworks exhibited in more than…
adVentures

Can we do something together?